Medicine catalog

Search official names, active ingredients, and BDPM codes. Cards show a readable name and form; the exact French source details are available below.

Total in catalog: 20,854 · 24 shown

Commercialized according to BDPM

POTELIGEO 4 mg/ml, concentrate for solution for infusion

Active ingredients: Mogamulizumab

Original BDPM details in French

Official name: POTELIGEO 4 mg/mL, solution à diluer pour perfusion
Active ingredients: MOGAMULIZUMAB
Package description: 1 flacon en verre de 5 mL

CIS 62292771CIP7 3022496CIP13 3400930224960

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

POTELIGEO 4 mg/ml, concentrate for solution for infusion

Active ingredients: Mogamulizumab

Original BDPM details in French

Official name: POTELIGEO 4 mg/mL, solution à diluer pour perfusion
Active ingredients: MOGAMULIZUMAB
Package description: 1 flacon en verre de 5 mL

CIS 62292771CIP7 5506040CIP13 3400955060406

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

BEKEMV 300 mg, concentrate for solution for infusion

Active ingredients: Eculizumab

Original BDPM details in French

Official name: BEKEMV 300 mg, solution à diluer pour perfusion
Active ingredients: ÉCULIZUMAB
Package description: 1 flacon en verre de 30 mL

CIS 63275561CIP7 5509565CIP13 3400955095651

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

EPYSQLI 300 mg, concentrate for solution for infusion

Active ingredients: Eculizumab

Original BDPM details in French

Official name: EPYSQLI 300 mg, solution à diluer pour perfusion
Active ingredients: ÉCULIZUMAB
Package description: 1 flacon(s) en verre de 30 ml

CIS 67665594CIP7 5509624CIP13 3400955096245

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

SOLIRIS 300 mg, concentrate for solution for infusion

Active ingredients: Eculizumab

Original BDPM details in French

Official name: SOLIRIS 300 mg, solution à diluer pour perfusion
Active ingredients: ÉCULIZUMAB
Package description: 1 flacon(s) en verre de 30 ml

CIS 61969188CIP7 5711384CIP13 3400957113841

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

ULTOMIRIS 1100 mg/11 ml, concentrate for solution for infusion

Active ingredients: Ravulizumab

Original BDPM details in French

Official name: ULTOMIRIS 1100 mg/11 mL, solution à diluer pour perfusion
Active ingredients: RAVULIZUMAB
Package description: 1 flacon(s) en verre de 11 ml

CIS 64265627CIP7 5508237CIP13 3400955082378

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

ULTOMIRIS 300 mg/3 ml, concentrate for solution for infusion

Active ingredients: Ravulizumab

Original BDPM details in French

Official name: ULTOMIRIS 300 mg/3 mL, solution à diluer pour perfusion
Active ingredients: RAVULIZUMAB
Package description: 1 flacon(s) en verre de 3 ml

CIS 61808523CIP7 5508238CIP13 3400955082385

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

AVTOZMA 162 mg, solution for injection in a pre-filled syringe

Active ingredients: Tocilizumab

Original BDPM details in French

Official name: AVTOZMA 162 mg, solution injectable en seringue préremplie
Active ingredients: TOCILIZUMAB
Package description: 1 seringue préremplie en verre de 0,9 mL

CIS 65554606CIP7 3030960CIP13 3400930309605

View details

Estimated price€245.30No current ANSM shortage notice is included

Commercialized according to BDPM

AVTOZMA 162 mg, solution for injection in a pre-filled pen

Active ingredients: Tocilizumab

Original BDPM details in French

Official name: AVTOZMA 162 mg, solution injectable en stylo prérempli
Active ingredients: TOCILIZUMAB
Package description: 1 seringue préremplie en verre dans stylo pré-rempli de 0,9 mL

CIS 65881305CIP7 3030963CIP13 3400930309636

View details

Estimated price€245.30No current ANSM shortage notice is included

Commercialized according to BDPM

AVTOZMA 20 mg/ml, concentrate for solution for infusion

Active ingredients: Tocilizumab

Original BDPM details in French

Official name: AVTOZMA 20 mg/mL, solution à diluer pour perfusion
Active ingredients: TOCILIZUMAB
Package description: 1 flacon en verre de 4 mL

CIS 60051070CIP7 5510608CIP13 3400955106081

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

AVTOZMA 20 mg/ml, concentrate for solution for infusion

Active ingredients: Tocilizumab

Original BDPM details in French

Official name: AVTOZMA 20 mg/mL, solution à diluer pour perfusion
Active ingredients: TOCILIZUMAB
Package description: 1 flacon en verre de 10 mL

CIS 60051070CIP7 5510610CIP13 3400955106104

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

AVTOZMA 20 mg/ml, concentrate for solution for infusion

Active ingredients: Tocilizumab

Original BDPM details in French

Official name: AVTOZMA 20 mg/mL, solution à diluer pour perfusion
Active ingredients: TOCILIZUMAB
Package description: 1 flacon en verre de 20 mL

CIS 60051070CIP7 5510612CIP13 3400955106128

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

ENTYVIO 108 mg, solution for injection in a pre-filled syringe

Active ingredients: VÉDOLIZUMAB

Original BDPM details in French

Official name: ENTYVIO 108 mg, solution injectable en seringue préremplie
Active ingredients: VÉDOLIZUMAB
Package description: 2 seringue(s) préremplie(s) en verre de 0,68 ml (conditionnement multiple)

CIS 69607230CIP7 3020866CIP13 3400930208663

View details

Estimated price€1,129.46No current ANSM shortage notice is included

Commercialized according to BDPM

ENTYVIO 108 mg, solution for injection in a pre-filled pen

Active ingredients: VÉDOLIZUMAB

Original BDPM details in French

Official name: ENTYVIO 108 mg, solution injectable en stylo prérempli
Active ingredients: VÉDOLIZUMAB
Package description: 2 stylos préremplis en verre de 0,68 ml (conditionnement multiple)

CIS 67320648CIP7 3020868CIP13 3400930208687

View details

Estimated price€1,129.46No current ANSM shortage notice is included

Commercialized according to BDPM

ENTYVIO 300 mg, powder for concentrate for infusion

Active ingredients: VÉDOLIZUMAB

Original BDPM details in French

Official name: ENTYVIO 300 mg, poudre pour solution à diluer pour perfusion
Active ingredients: VÉDOLIZUMAB
Package description: 1 flacon(s) en verre

CIS 66320218CIP7 5867287CIP13 3400958672873

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

NEMLUVIO 30 mg, powder and solvent for solution for injection in a pre-filled pen

Active ingredients: NÉMOLIZUMAB

Original BDPM details in French

Official name: NEMLUVIO 30 mg, poudre et solvant pour solution injectable en stylo prérempli
Active ingredients: NÉMOLIZUMAB
Package description: 1 cartouche à double chambre en verre en stylo pré-rempli de 30 mg de poudre et de 0,49 mL de solvant

CIS 60661547CIP7 3031530CIP13 3400930315309

View details

Estimated price€4,016.90No current ANSM shortage notice is included

Commercialized according to BDPM

NUCALA 100 mg, powder for solution for injection

Active ingredients: MÉPOLIZUMAB

Original BDPM details in French

Official name: NUCALA 100 mg, poudre pour solution injectable
Active ingredients: MÉPOLIZUMAB
Package description: 1 flacon(s) en verre

CIS 65864619CIP7 3003835CIP13 3400930038352

View details

Estimated price€1,836.04No current ANSM shortage notice is included

Commercialized according to BDPM

NUCALA 100 mg, solution for injection in a pre-filled syringe

Active ingredients: MÉPOLIZUMAB

Original BDPM details in French

Official name: NUCALA 100 mg, solution injectable en seringue préremplie
Active ingredients: MÉPOLIZUMAB
Package description: 1 seringue préremplie en verre de 1 mL

CIS 66719612CIP7 3018633CIP13 3400930186336

View details

Estimated price€1,837.32No current ANSM shortage notice is included

Commercialized according to BDPM

NUCALA 100 mg, solution for injection in a pre-filled pen

Active ingredients: MÉPOLIZUMAB

Original BDPM details in French

Official name: NUCALA 100 mg, solution injectable en stylo prérempli
Active ingredients: MÉPOLIZUMAB
Package description: 1 stylo prérempli en verre de 1 ml

CIS 63236206CIP7 3018634CIP13 3400930186343

View details

Estimated price€1,837.32No current ANSM shortage notice is included

Commercialized according to BDPM

NUCALA 100 mg, solution for injection in a pre-filled pen

Active ingredients: MÉPOLIZUMAB

Original BDPM details in French

Official name: NUCALA 100 mg, solution injectable en stylo prérempli
Active ingredients: MÉPOLIZUMAB
Package description: 3 stylos préremplis en verre de 1 mL

CIS 63236206CIP7 3025056CIP13 3400930250563

View details

Estimated price€5,316.24No current ANSM shortage notice is included

Commercialized according to BDPM

NUCALA 40 mg, solution for injection in a pre-filled syringe

Active ingredients: MÉPOLIZUMAB

Original BDPM details in French

Official name: NUCALA 40 mg, solution injectable en seringue préremplie
Active ingredients: MÉPOLIZUMAB
Package description: 1 seringue(s) préremplie(s) en verre de 0,4 ml

CIS 67361794CIP7 3025043CIP13 3400930250433

View details

Estimated price€1,837.32No current ANSM shortage notice is included

Commercialized according to BDPM

OCREVUS 300 mg, concentrate for solution for infusion

Active ingredients: OCRÉLIZUMAB

Original BDPM details in French

Official name: OCREVUS 300 mg, solution à diluer pour perfusion
Active ingredients: OCRÉLIZUMAB
Package description: 1 flacon en verre de 10 mL

CIS 66127361CIP7 5504836CIP13 3400955048367

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

OCREVUS 920 mg, solution for injection

Active ingredients: OCRÉLIZUMAB

Original BDPM details in French

Official name: OCREVUS 920 mg, solution injectable
Active ingredients: OCRÉLIZUMAB
Package description: 1 flacon en verre de 23 mL

CIS 62251899CIP7 5510189CIP13 3400955101895

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

OMLYCLO 150 mg, solution for injection in a pre-filled syringe

Active ingredients: Omalizumab

Original BDPM details in French

Official name: OMLYCLO 150 mg, solution injectable en seringue préremplie
Active ingredients: OMALIZUMAB
Package description: 1 seringue préremplie en verre de 1 mL

CIS 69603381CIP7 3029436CIP13 3400930294369

View details

Estimated price€312.48No current ANSM shortage notice is included

The displayed price is an estimate. It is not an offer to sell or confirmation of stock. Current catalog version published 4 Nov 2026.